Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles. 2001

D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
Chemical Sciences and Oncology, Wyeth-Ayerst Research, 401 North Middletown Road, Pearl River, New York 10965, USA. bosched@war.wyeth.com

Screening of a directed compound library in a yeast-based assay identified 4-[(2,4-dichlorophenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile (2a) as a Src inhibitor. An enzymatic assay established that 2a was an ATP-competitive inhibitor of the kinase activity of Src. We present here SAR data for 2a which shows that the aniline group at C-4, the carbonitrile group at C-3, and the alkoxy groups at C-6 and C-7 of the quinoline are crucial for optimal activity. Increasing the size of the C-2 substituent of the aniline at C-4 of 2a from chloro to bromo to iodo resulted in a corresponding increase in Src inhibition. Furthermore, replacement of the 7-methoxy group of 2a with various 3-heteroalkylaminopropoxy groups provided increased inhibition of both Src enzymatic and cellular activity. Compound 25, which contains a 3-morpholinopropoxy group, had an IC(50) of 3.8 nM in the Src enzymatic assay and an IC(50) of 940 nM for the inhibition of Src-dependent cell proliferation.

UI MeSH Term Description Entries
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011804 Quinolines
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
March 2007, Bioorganic & medicinal chemistry letters,
D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
May 2004, Bioorganic & medicinal chemistry letters,
D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
September 2009, Bioorganic & medicinal chemistry letters,
D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
October 2002, Bioorganic & medicinal chemistry letters,
D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
September 2010, Biochimie,
D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
June 2008, Bioorganic & medicinal chemistry,
D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
September 2002, Current topics in medicinal chemistry,
D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
October 2009, Journal of enzyme inhibition and medicinal chemistry,
D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
May 2009, Bioorganic & medicinal chemistry letters,
D H Boschelli, and Y D Wang, and F Ye, and B Wu, and N Zhang, and M Dutia, and D W Powell, and A Wissner, and K Arndt, and J M Weber, and F Boschelli
July 2012, Chemical biology & drug design,
Copied contents to your clipboard!